1. Academic Validation
  2. An early, novel arginine methylation of KCa3.1 attenuates subsequent T cell exhaustion

An early, novel arginine methylation of KCa3.1 attenuates subsequent T cell exhaustion

  • bioRxiv. 2024 Nov 20:2024.05.09.593421. doi: 10.1101/2024.05.09.593421.
Piyush Sharma Ao Guo Suresh Poudel Emilio Boada-Romero Katherine C Verbist Gustavo Palacios Kalyan Immadisetty Mark J Chen Dalia Haydar Ashutosh Mishra Junmin Peng M Madan Babu Giedre Krenciute Evan S Glazer Douglas R Green
Abstract

T cell receptor (TCR) engagement initiates the activation process, and this signaling event is regulated in multifaceted ways. Nutrient availability in the immediate niche is one such mode of regulation 1-3 . Here, we investigated how the availability of an essential amino acid methionine (Met) and TCR signaling might interplay in the earliest events of T cell activation to affect subsequent T cell fate and function. We found that limiting Met during only the initial 30 minutes of CD8 + T cell activation increased CA 2+ influx, CA 2+ -mediated NFAT1 ( Nfatc2 ) activation, NFAT1 promoter occupancy, and T cell exhaustion. We identified changes in the protein arginine methylome during the initial 30 min of TCR engagement and discovered a novel arginine methylation of a CA 2+ -activated potassium transporter, KCa3.1, which regulates CA 2+ -mediated NFAT1 signaling to ensure optimal activation. Ablation of arginine methylation in KCa3.1 led to increased NFAT1 activation, rendering T cells dysfunctional in murine tumour and Infection models. Furthermore, acute Met supplementation at early stages reduced nuclear NFAT1 in tumour-infiltrating T cells and augmented their anti-tumour activity. Our findings identify a metabolic event occurring early after T cell activation that influences the subsequent fate of the cell.

Figures
Products